- On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Half of 2023 - WALTHAM, Mass., May 11, 2023 Dyne. | May 11, 2023
Ultomiris Gets EU Approval for Neuromyelitis Optica Spectrum Disorder in Adults miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
CAPE CANAVERAL, Fla., May 09, 2023 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first. | May 9, 2023
Researchers from the Perelman School of Medicine at the University of Pennsylvania will present data on the latest research across the full spectrum of Neurology at the American Academy of Neurology (AAN) Annual Meeting from April 22-27 in Boston, Ma